| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |